StockData
Nephros Inc logo

Nephros Inc (NEPH) stock

NEPHNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 13/3020% below fair value
$3.00−0.05 (-1.64%)

Close on Nov 16, 2026Market cap $32.58MP/E 18.8Yield –

Nephros cash

Cash and short-term investments held at the end of each period.

Nephros's cash was $4.70M at Jun 30, 2026. For fiscal 2025 it was $5.40M, up 43.6% from the year before. Over ten years it grew 15.8% a year on average. The highest annual figure on record is $8.25M in fiscal 2020.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$5.40M+43.6%
FY2024Dec 31, 2024$3.76M-12.7%
FY2023Dec 31, 2023$4.31M+18.5%
FY2022Dec 31, 2022$3.63M-47.9%
FY2021Dec 31, 2021$6.97M-15.5%
FY2020Dec 31, 2020$8.25M+98.0%
FY2019Dec 31, 2019$4.17M-9.1%
FY2018Dec 31, 2018$4.58M+108.8%
FY2017Dec 31, 2017$2.19M+697.8%
FY2016Dec 31, 2016$275.00K-78.0%
FY2015Dec 31, 2015$1.25M-2.8%
FY2014Dec 31, 2014$1.28M+121.8%
FY2013Dec 31, 2013$579.00K+1131.9%
FY2012Dec 31, 2012$47.00K-97.2%
FY2011Dec 31, 2011$1.67M+595.4%
FY2010Dec 31, 2010$240.00K-76.1%
FY2009Dec 31, 2009$1.00M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$4.70M-7.4%
Q1 FY2026Mar 31, 2026$4.02M-1.5%
Q4 FY2025Dec 31, 2025$5.40M+43.6%
Q3 FY2025Sep 30, 2025$5.17M+110.5%
Q2 FY2025Jun 30, 2025$5.07M+64.7%
Q1 FY2025Mar 31, 2025$4.08M+12.3%
Q4 FY2024Dec 31, 2024$3.76M-12.7%
Q3 FY2024Sep 30, 2024$2.46M-46.8%
Q2 FY2024Jun 30, 2024$3.08M-24.1%
Q1 FY2024Mar 31, 2024$3.63M-5.3%
Q4 FY2023Dec 31, 2023$4.31M+18.5%
Q3 FY2023Sep 30, 2023$4.62M+17.3%
Q2 FY2023Jun 30, 2023$4.06M-2.8%
Q1 FY2023Mar 31, 2023$3.84M-29.2%
Q4 FY2022Dec 31, 2022$3.63M-47.9%
Q3 FY2022Sep 30, 2022$3.94M-46.4%
Q2 FY2022Jun 30, 2022$4.18M-49.5%
Q1 FY2022Mar 31, 2022$5.42M-33.6%
Q4 FY2021Dec 31, 2021$6.97M-15.5%
Q3 FY2021Sep 30, 2021$7.35M+42.6%
Q2 FY2021Jun 30, 2021$8.28M+17.5%
Q1 FY2021Mar 31, 2021$8.16M-8.9%
Q4 FY2020Dec 31, 2020$8.25M+98.0%
Q3 FY2020Sep 30, 2020$5.16M+33.7%
Q2 FY2020Jun 30, 2020$7.05M+63.2%
Q1 FY2020Mar 31, 2020$8.96M+148.4%
Q4 FY2019Dec 31, 2019$4.17M-9.1%
Q3 FY2019Sep 30, 2019$3.86M-27.6%
Q2 FY2019Jun 30, 2019$4.32M+23.9%
Q1 FY2019Mar 31, 2019$3.61M+98.4%
Q4 FY2018Dec 31, 2018$4.58M+108.8%
Q3 FY2018Sep 30, 2018$5.32M+3448.0%
Q2 FY2018Jun 30, 2018$3.48M+1057.5%
Q1 FY2018Mar 31, 2018$1.82M+126.5%
Q4 FY2017Dec 31, 2017$2.19M+697.8%
Q3 FY2017Sep 30, 2017$150.00K-81.4%
Q2 FY2017Jun 30, 2017$301.00K–
Q1 FY2017Mar 31, 2017$803.00K–
Q4 FY2016Dec 31, 2016$275.00K–
Q3 FY2016Sep 30, 2016$807.00K–

More Nephros figures

See a number that looks wrong?